Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PCSK9
Pharma
Carvykti, Sangon, China and more—Fierce Pharma Asia
Carvykti grows despite bispecific competition. Novo joins a Chinese firm's $290M financing round. China woos foreign biotech investments. And more.
Angus Liu
Aug 18, 2023 9:10am
Sanofi, Regeneron clinch win in PCSK9 patent feud with Amgen
May 18, 2023 3:16pm
Samsung, Olympus, Dr. Reddy's—Fierce Pharma Asia
Mar 3, 2023 9:45am
Amgen garners wide support in SCOTUS patent fight with Sanofi
Jan 4, 2023 11:38am
In SCOTUS appeal, Amgen gets chance to argue Repatha case
Nov 7, 2022 8:53am
Lilly-Innovent, Novartis, Moderna and more—Fierce Pharma Asia
Feb 18, 2022 9:15am
